New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Clinical trial tests pirtobrutinib for patients previously treated for mantle cell lymphoma

Clinical trial tests pirtobrutinib for patients previously treated for mantle cell lymphoma

byMedical College of WisconsinCredit: Pixabay/CC0 Public DomainIn a multi-center phase 1 and 2 trial (BRUIN, NCT03740529), researchers from leading cancer centers across the globe, including the
World medicine December 12,2023
Clinical trial tests pirtobrutinib for patients previously treated for mantle cell lymphoma

Clinical trial tests pirtobrutinib for patients previously treated for mantle cell lymphoma

byMedical College of WisconsinCredit: Pixabay/CC0 Public DomainIn a multi-center phase 1 and 2 trial (BRUIN, NCT03740529), researchers from leading cancer centers across the globe, including the
World medicine December 12,2023
Clinical screening can identify fear of cancer recurrence

Clinical screening can identify fear of cancer recurrence

by Ben Knight,University of New South WalesCredit: AI-generated imageFear of cancer recurrence (FCR) is one of the most common and distressing concerns cancer survivors have. For many, it can be
World medicine December 12,2023
Clinical screening can identify fear of cancer recurrence

Clinical screening can identify fear of cancer recurrence

by Ben Knight,University of New South WalesCredit: AI-generated imageFear of cancer recurrence (FCR) is one of the most common and distressing concerns cancer survivors have. For many, it can be
World medicine December 12,2023
Two studies find role for alternative lengthening of telomeres in treatment-resistant tumors

Two studies find role for alternative lengthening of telomeres in treatment-resistant tumors

byChildren's Hospital of PhiladelphiaRepresentative images from subject 3 who had both measurable and MIBG-evaluable neuroblastoma and an overall central radiology reviewed PR from cycles 3
World medicine December 12,2023
Two studies find role for alternative lengthening of telomeres in treatment-resistant tumors

Two studies find role for alternative lengthening of telomeres in treatment-resistant tumors

byChildren's Hospital of PhiladelphiaRepresentative images from subject 3 who had both measurable and MIBG-evaluable neuroblastoma and an overall central radiology reviewed PR from cycles 3
World medicine December 12,2023
Good cardiorespiratory fitness associated with up to 40% lower risk of 9 cancers

Good cardiorespiratory fitness associated with up to 40% lower risk of 9 cancers

byBritish Medical JournalCredit: CC0 Public DomainGood cardiorespiratory fitness when young is associated with up to a 40% lower risk of developing 9 specific cancers later on—at least in men—su
World medicine December 12,2023
Good cardiorespiratory fitness associated with up to 40% lower risk of 9 cancers

Good cardiorespiratory fitness associated with up to 40% lower risk of 9 cancers

byBritish Medical JournalCredit: CC0 Public DomainGood cardiorespiratory fitness when young is associated with up to a 40% lower risk of developing 9 specific cancers later on—at least in men—su
World medicine December 12,2023
Combination therapy can prevent resistance to treatment in hormone responsive metastatic breast cancer patients

Combination therapy can prevent resistance to treatment in hormone responsive metastatic breast cancer patients

by Instituto de Medicina MolecularGraphical Abstract. Credit:Cell Reports Medicine(2023). DOI: 10.1016/j.xcrm.2023.101120Breast cancer is a heterogeneous disease, but 70% of cases are char
World medicine December 12,2023
Combination therapy can prevent resistance to treatment in hormone responsive metastatic breast cancer patients

Combination therapy can prevent resistance to treatment in hormone responsive metastatic breast cancer patients

by Instituto de Medicina MolecularGraphical Abstract. Credit:Cell Reports Medicine(2023). DOI: 10.1016/j.xcrm.2023.101120Breast cancer is a heterogeneous disease, but 70% of cases are char
World medicine December 12,2023
New leukemia treatment-response 'crystal ball' discovered using AI

New leukemia treatment-response 'crystal ball' discovered using AI

by Federico Graciano,Duke-NUS Medical SchoolCredit: Unsplash/CC0 Public DomainScientists at Duke-NUS Medical School, A*STAR's Genome Institute of Singapore (GIS), Singapore General Hospital
World medicine December 12,2023
New leukemia treatment-response 'crystal ball' discovered using AI

New leukemia treatment-response 'crystal ball' discovered using AI

by Federico Graciano,Duke-NUS Medical SchoolCredit: Unsplash/CC0 Public DomainScientists at Duke-NUS Medical School, A*STAR's Genome Institute of Singapore (GIS), Singapore General Hospital
World medicine December 12,2023
Using the immune system to stop ovarian cancer

Using the immune system to stop ovarian cancer

byHudson Institute of Medical ResearchSuppression of epithelial IFNε in HGSOC and anti-tumor properties.a,b, IHC staining of human FT from two healthy women using rabbit anti-human IFNε (m
World medicine December 12,2023
Using the immune system to stop ovarian cancer

Using the immune system to stop ovarian cancer

byHudson Institute of Medical ResearchSuppression of epithelial IFNε in HGSOC and anti-tumor properties.a,b, IHC staining of human FT from two healthy women using rabbit anti-human IFNε (m
World medicine December 12,2023
Leveraging phosphorothioate backbone modification to optimize aptamer-drug conjugates for therapeutic agent delivery

Leveraging phosphorothioate backbone modification to optimize aptamer-drug conjugates for therapeutic agent delivery

byScience China Pressa) Cell uptake efficiency of Cy5-XQ-2d, Cy5-S-XQ-2d, Cy5-MFSX, and Cy5-MFC by PL45 cells. b) The ratio of Geometric Mean Fluorescence Intensity to Cy5-MFC for Cy5-XQ-2d, Cy5
World medicine December 12,2023
Leveraging phosphorothioate backbone modification to optimize aptamer-drug conjugates for therapeutic agent delivery

Leveraging phosphorothioate backbone modification to optimize aptamer-drug conjugates for therapeutic agent delivery

byScience China Pressa) Cell uptake efficiency of Cy5-XQ-2d, Cy5-S-XQ-2d, Cy5-MFSX, and Cy5-MFC by PL45 cells. b) The ratio of Geometric Mean Fluorescence Intensity to Cy5-MFC for Cy5-XQ-2d, Cy5
World medicine December 12,2023
Understanding the tumor microenvironment with photoacoustic spectral analysis

Understanding the tumor microenvironment with photoacoustic spectral analysis

bySPIEPhotoacoustic spectral analysis (PASA) involves shining laser pulses of various wavelengths at a target tissue and measuring the generated ultrasonic waves with a hydrophone. These signals
World medicine December 12,2023
Understanding the tumor microenvironment with photoacoustic spectral analysis

Understanding the tumor microenvironment with photoacoustic spectral analysis

bySPIEPhotoacoustic spectral analysis (PASA) involves shining laser pulses of various wavelengths at a target tissue and measuring the generated ultrasonic waves with a hydrophone. These signals
World medicine December 12,2023
Riluzole and sorafenib in patients with advanced solid tumors: A phase I trial

Riluzole and sorafenib in patients with advanced solid tumors: A phase I trial

by Impact Journals LLCPre- and post-treatment scans confirmed partial responder. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28403A new research paper titled "A phase I trial of
World medicine December 12,2023
Riluzole and sorafenib in patients with advanced solid tumors: A phase I trial

Riluzole and sorafenib in patients with advanced solid tumors: A phase I trial

by Impact Journals LLCPre- and post-treatment scans confirmed partial responder. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28403A new research paper titled "A phase I trial of
World medicine December 12,2023
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com